Spots Global Cancer Trial Database for therapeutic vaccine
Every month we try and update this database with for therapeutic vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer | NCT06157151 | Cervical Cancer HPV-Related Car... HPV-Related Mal... | PRGN-2009 plus ... Pembrolizumab a... | 18 Years - | Precigen, Inc | |
| PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer | NCT06157151 | Cervical Cancer HPV-Related Car... HPV-Related Mal... | PRGN-2009 plus ... Pembrolizumab a... | 18 Years - | Precigen, Inc | |
| Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer | NCT01823978 | Castrate Resist... | BPX-201 vaccine... | 18 Years - | Bellicum Pharmaceuticals | |
| PROvenge Treatment and Early Cancer Treatment | NCT00779402 | Prostate Cancer | Control Sipuleucel-T | 18 Years - 80 Years | Dendreon | |
| Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer | NCT01823978 | Castrate Resist... | BPX-201 vaccine... | 18 Years - | Bellicum Pharmaceuticals | |
| Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers | NCT03260023 | HPV-Related Car... HPV-Related Cer... HPV-Related Ana... HPV-Related Pen... HPV-Related Vul... | TG4001 Avelumab | 18 Years - | Transgene | |
| Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment | NCT03525652 | Prostate Cancer | Therapeutic vac... PD-1 Knockout T... | 18 Years - 70 Years | The First Affiliated Hospital of Guangdong Pharmaceutical University | |
| Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | NCT04892043 | Adult Solid Tum... | SQZ-AAC-HPV Ipilimumab Nivolumab | 18 Years - | SQZ Biotechnologies | |
| Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts | NCT02750202 | Genital Warts | Quadrivalent HP... Hepatitis B vac... | 16 Years - | University of Pretoria | |
| Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers | NCT03260023 | HPV-Related Car... HPV-Related Cer... HPV-Related Ana... HPV-Related Pen... HPV-Related Vul... | TG4001 Avelumab | 18 Years - | Transgene | |
| Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | NCT04892043 | Adult Solid Tum... | SQZ-AAC-HPV Ipilimumab Nivolumab | 18 Years - | SQZ Biotechnologies | |
| Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | NCT04084951 | Adult Solid Tum... | SQZ-PBMC-HPV Atezolizumab Ipilimumab Nivolumab | 18 Years - | SQZ Biotechnologies | |
| A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer | NCT02293707 | Prostate Cancer | GX301 | 18 Years - | Laboratoires Leurquin Mediolanum | |
| Immunotherapy With Racotumomab in Advanced Lung Cancer | NCT01460472 | NSCLC Lung Cancer, No... | Racotumomab Best Support Tr... | 18 Years - | Recombio SL | |
| Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer | NCT01431391 | Prostatic Neopl... Prostate Cancer Prostatic Adeno... | sipuleucel-T leuprolide acet... | 18 Years - | Dendreon | |
| Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | NCT00065442 | Prostate Cancer | Sipuleucel-T APC-Placebo | 18 Years - | Dendreon | |
| Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | NCT05357898 | Adult Solid Tum... | SQZ-eAPC-HPV Pembrolizumab | 18 Years - | SQZ Biotechnologies |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
